|
| Status |
Public on Jan 31, 2007 |
| Title |
A30055 |
| Sample type |
RNA |
| |
|
| Source name |
bone marrow from AML patient
|
| Organism |
Homo sapiens |
| Characteristics |
AML class: RELAPSED
Sex: FEMALE
Age: 71
Best Response: No response
Survival time: 56
|
| Extracted molecule |
total RNA |
| Extraction protocol |
Total RNA was isolated from bone marrow of AML patients using Qiagen Rneasy Kit.
|
| Label |
biotin
|
| Label protocol |
Approximately 5 µg of total RNA was processed to produce biotinylated cRNA targets.
|
| |
|
| Hybridization protocol |
standard Affymetrix procedures
|
| Scan protocol |
standard Affymetrix procedures
|
| Description |
NA
|
| Data processing |
Affymetrix Microarray Suite version 5.0
|
| |
|
| Submission date |
Jun 21, 2006 |
| Last update date |
Dec 03, 2008 |
| Contact name |
Jack Yu |
| E-mail(s) |
jyu9@VRXUS.jnj.com
|
| Phone |
858-320-3362
|
| Fax |
858-784-3182
|
| Organization name |
Veridex, LLC
|
| Street address |
3210 Merryfield Row
|
| City |
San Diego |
| State/province |
CA |
| ZIP/Postal code |
92121 |
| Country |
USA |
| |
|
| Platform ID |
GPL96 |
| Series (1) |
| GSE5122 |
Identification of molecular predictors of response in a study of tipifarnib treatment in relapsed and refractory AML |
|
